Business - Briefly   

Strides Arcolab gets first U.S. ANDA approval

MUMBAI: Strides Arcolab has informed the Bombay Stock Exchange that it has received tentative approval from the U.S. Food and Drug Administration for Nevirapine (a key anti-retro viral in the treatment of AIDS) tablets 200 mg. The application was reviewed under the expedited review provisions of the President's Emergency Plan for Aids Relief.

Printer friendly page  
Send this article to Friends by E-Mail

Stories in this Section

Push for new technology in farming favoured
Indra Nooyi named global CEO of PepsiCo
i-flex solutions to acquire Mantas for $122.6 m
Sensex gains 121 points
Rupee ends lower
Ranbaxy gets nod to sell HIV drug for children
Tata ferro chrome unit in SA to kick-start soon
ONGC bags block in Colombia
Post Offices to market TVS Finance products
GMR hives off ferro alloys division to separate unit
Exchange rates
Bullion rates
Cess bill gets Parliament nod
Base import prices hiked
SpiceJet signs $1.1 b aircraft deal
FFS buys stake in Asian CERC IT
`Extend TRAI Chairman's term'
BHEL bags power plant contract in U.P.
VBC Ind to merge Bharat Alloys with itself
Strides Arcolab gets first U.S. ANDA approval
Duty exemption sought for synthetic diamonds
Adani Exports renamed to Adani Enterprises
New CMO for UTI AMC
GDA to expand Chennai operations
Gulf Air wins award from Airbus

Copyright © 2006, The Hindu. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu